This Act changes the eligibility for Delaware's Family and Medical Leave Insurance Program ("Program") by removing the requirement that an individual be employed for at least 12 months by an employer with respect to whom leave is requested. This change would make eligible for the Program individuals who meet the hours-of-service requirement in less than 12 months.
This bill proclaims September 2026 as Suicide Prevention Awareness Month in California to raise visibility for mental health resources and reduce stigma. The resolution highlights the severity of suicide as a public health issue, citing statistics on death rates and the increased risk faced by specific groups such as LGBTQIA+ youth and veterans. It encourages residents to openly discuss mental well-being and directs attention to existing support services like the 988 lifeline and local crisis centers.
This Senate Resolution highlights the importance of medically supportive food and nutrition services, often called "food as medicine," in improving health outcomes and reducing healthcare costs for Californians. It notes that these services, which include medically tailored meals and groceries, are already a key part of the state's Medi-Cal program and have been shown to lower emergency room visits and hospitalizations. The resolution emphasizes the value of these programs in addressing diet-related health issues and encourages continued collaboration among healthcare providers and community organizations to expand access. Additionally, it supports sourcing food from local farms to benefit the economy and environment while ensuring high-quality, culturally relevant care for patients.
This Senate Resolution officially designates September 2026 as Ovarian Cancer Awareness Month in California. The bill aims to highlight the severity of the disease and encourage women to seek early medical attention for symptoms like bloating and pelvic pain. It does not change laws or allocate funding but serves to raise public awareness and support for those affected by ovarian cancer.
Senate Resolution 122 formally recognizes November 2026 as Pancreatic Cancer Awareness Month in California. This non-binding resolution highlights the severity of the disease, noting its high mortality rate and lack of early detection methods, while also pointing out that current federal funding for pancreatic cancer research is low compared to other areas. The bill urges all Californians to take action to end pancreatic cancer and calls for increased awareness and support for research efforts. It does not change any laws or allocate state funds but serves to draw public attention to the issue.
This bill establishes a comprehensive federal program to reduce medical errors and waste caused by misdiagnoses by funding research, developing new tools, and training healthcare professionals. It creates a new interagency council and research centers to study diagnostic failures, while also setting up a safe, voluntary reporting system for patients to share their experiences without fear of legal repercussions. The legislation authorizes funding over several years to support these initiatives, standardize medical data for better analysis, and ensure that patient perspectives are central to improving how diagnoses are made and managed across the healthcare system.
The TRUTH in Coverage Act of 2026 requires group health plans and health insurance issuers that cover gender-affirming procedures to also cover medical services intended to treat physical and psychological complications resulting from those procedures. This mandate applies regardless of whether the original gender-affirming treatment was covered by the plan and ensures that any required follow-up care faces the same cost-sharing rules and limitations as standard medical benefits. The bill defines "sex-rejecting procedures" broadly to include hormone therapy, surgeries, and puberty blockers, while explicitly excluding treatments for intersex conditions, life-threatening emergencies, and standard puberty suppression for early puberty. These provisions would take effect for plan years beginning on or after January 1, 2027, affecting individuals with access to employer-sponsored or individual health insurance.
The Mamas First Act aims to reduce maternal mortality rates by expanding Medicaid coverage to include support services from doulas, midwives, tribal midwives, and lactation providers. This legislation modifies the Social Security Act to allow these professionals to bill Medicaid for prenatal, labor, and postpartum care delivered in various settings, including homes, hospitals, and clinics. To qualify for reimbursement, doulas must hold a certification requiring continuing education and gather specific client or provider recommendations, while midwives and lactation support providers must meet defined state or international standards. The bill also prohibits Medicaid programs from charging copayments or deductibles for these essential services, with the changes taking effect on January 1, 2027.
The SECURE 340B Act strengthens oversight of the drug discount program for safety-net health care providers by establishing clearer definitions for patients and prescribing providers, requiring detailed record-keeping to prove a legitimate patient relationship. The bill introduces strict rules for contract pharmacies, mandating that manufacturers cannot restrict discounts based on their use and requiring full transparency on where these drugs are dispensed. It also expands eligibility for child sites of covered entities while imposing a new community need standard based on geographic vulnerability scores to prevent abuse. To improve program integrity, the legislation creates a centralized data clearinghouse to track claims and prevent duplicate discounts, while simultaneously prohibiting discriminatory practices by insurance companies and pharmacy benefit managers against covered entities. Finally, the Act authorizes new user fees and additional funding for the Health Resources and Services Administration to support expanded audits and enforcement activities.
The Medicare Advantage Supplemental Benefits Transparency Act of 2026 requires Medicare Advantage plans to submit detailed data on supplemental benefits to the federal government starting in 2029. This information will include specific details about what benefits are offered, eligibility rules, and how much each enrollee spends on these services. The Centers for Medicare & Medicaid Services will then make this de-identified data available to the public and researchers for analysis after a two-year delay. To support the implementation of these reporting requirements, the bill appropriates $12 million for fiscal year 2026.
